Hinge Health, Inc. is trading 4.6% up now at $65.65 after the company raised its 2026 revenue guidance ahead of its first Investor Day.

  • The company now expects second-quarter 2026 revenue of $200–$202 million and full-year 2026 revenue of $818–$824 million.
  • The updated outlook reflects strong business momentum and improved non-GAAP operating margin expectations, which investors are reacting to positively.